PNC Financial Services Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$184K Buy
917
+23
+3% +$4.76K ﹤0.01% 2382
2025
Q4
$185K Hold
894
﹤0.01% 2369
2025
Q3
$160K Hold
894
﹤0.01% 2448
2025
Q2
$144K Sell
894
-176
-16% -$28K ﹤0.01% 2444
2025
Q1
$182K Buy
1,070
+26
+2% +$4.51K ﹤0.01% 2233
2024
Q4
$174K Buy
1,044
+60
+6% +$10.3K ﹤0.01% 2318
2024
Q3
$169K Buy
984
+136
+16% +$22.5K ﹤0.01% 2320
2024
Q2
$131K Hold
848
﹤0.01% 2441
2024
Q1
$130K Sell
848
-153
-15% -$23.3K ﹤0.01% 2446
2023
Q4
$158K Sell
1,001
-932
-48% -$134K ﹤0.01% 2318
2023
Q3
$283K Sell
1,933
-50
-3% -$7.62K ﹤0.01% 1873
2023
Q2
$304K Sell
1,983
-122
-6% -$19K ﹤0.01% 1912
2023
Q1
$326K Buy
2,105
+324
+18% +$50.9K ﹤0.01% 1824
2022
Q4
$275K Sell
1,781
-371
-17% -$54.7K ﹤0.01% 1921
2022
Q3
$284K Sell
2,152
-132
-6% -$18.5K ﹤0.01% 1871
2022
Q2
$310K Hold
2,284
﹤0.01% 1849
2022
Q1
$340K Sell
2,284
-263
-10% -$38.9K ﹤0.01% 1926
2021
Q4
$413K Sell
2,547
-383
-13% -$61.9K ﹤0.01% 1822
2021
Q3
$487K Sell
2,930
-70
-2% -$12K ﹤0.01% 1623
2021
Q2
$518K Sell
3,000
-286
-9% -$47.2K ﹤0.01% 1584
2021
Q1
$527K Sell
3,286
-40
-1% -$6.85K ﹤0.01% 1531
2020
Q4
$558K Sell
3,326
-292
-8% -$47.4K ﹤0.01% 1412
2020
Q3
$569K Buy
3,618
+319
+10% +$52.1K ﹤0.01% 1287
2020
Q2
$553K Sell
3,299
-2,754
-45% -$432K ﹤0.01% 1326
2020
Q1
$794K Buy
6,053
+398
+7% +$56.7K ﹤0.01% 1064
2019
Q4
$841K Sell
5,655
-170
-3% -$23.3K ﹤0.01% 1171
2019
Q3
$721K Sell
5,825
-26
-0.4% -$3.46K ﹤0.01% 1404
2019
Q2
$824K Sell
5,851
-158
-3% -$21.8K ﹤0.01% 1361
2019
Q1
$906K Buy
6,009
+693
+13% +$99.7K ﹤0.01% 1336
2018
Q4
$661K Buy
5,316
+1,355
+34% +$185K ﹤0.01% 1423
2018
Q3
$628K Buy
3,961
+594
+18% +$89.9K ﹤0.01% 1550
2018
Q2
$472K Buy
3,367
+445
+15% +$61.1K ﹤0.01% 1693
2018
Q1
$388K Sell
2,922
-77
-3% -$10.5K ﹤0.01% 1785
2017
Q4
$373K Sell
2,999
-207
-6% -$25.6K ﹤0.01% 1817
2017
Q3
$398K Buy
3,206
+717
+29% +$84.9K ﹤0.01% 1747
2017
Q2
$284K Sell
2,489
-175
-7% -$18.8K ﹤0.01% 1931
2017
Q1
$281K Sell
2,664
-365
-12% -$36.6K ﹤0.01% 1940
2016
Q4
$275K Sell
3,029
-1,293
-30% -$121K ﹤0.01% 1942
2016
Q3
$431K Sell
4,322
-151
-3% -$14.8K ﹤0.01% 1631
2016
Q2
$400K Sell
4,473
-523
-10% -$48K ﹤0.01% 1668
2016
Q1
$437K Sell
4,996
-9,073
-64% -$799K ﹤0.01% 1629
2015
Q4
$1.59M Sell
14,069
-854
-6% -$91.9K ﹤0.01% 1006
2015
Q3
$1.51M Buy
14,923
+1,118
+8% +$133K ﹤0.01% 1067
2015
Q2
$1.71M Sell
13,805
-701
-5% -$84.6K ﹤0.01% 1044
2015
Q1
$1.71M Buy
14,506
+13,984
+2,679% +$1.58M ﹤0.01% 1024
2014
Q4
$54K Buy
522
+264
+102% +$25.8K ﹤0.01% 2758
2014
Q3
$24K Sell
258
-121
-32% -$10.5K ﹤0.01% 2982
2014
Q2
$31K Buy
379
+229
+153% +$17.5K ﹤0.01% 2759
2014
Q1
$12K Hold
150
﹤0.01% 3001
2013
Q4
$10K Hold
150
﹤0.01% 2982
2013
Q3
$10K Hold
150
﹤0.01% 3259
2013
Q2
$9K Buy
+150
New +$8.57K ﹤0.01% 3172

Other funds holding FBT

PNC Financial Services Group's FBT Position: Q1 2026 in Review

PNC Financial Services Group increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 2.6% in Q1 2026, buying an estimated $4.76K and bringing the position to 917 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #2382.

PNC Financial Services Group first reported a position in FBT in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.71M in Q1 2015. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • PNC Financial Services Group held 917 shares of First Trust NYSE Arca Biotechnology Index Fund worth $184K as of Q1 2026.
  • PNC Financial Services Group bought 23 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $4.76K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #2382 holding.
  • PNC Financial Services Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 52 quarters since.
  • PNC Financial Services Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.71M in Q1 2015.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.